Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Anticancer Research|November 1, 2023
CA19-9 With Two-stage Resection Is Useful for Conversion Surgery in PDAC With Synchronous OligometastasesKoetsu Inoue, Masamichi Mizuma, Fuyuhiko Motoi, et al.
Cancer Science|September 9, 2023
Collagen XVII regulates tumor growth in pancreatic cancer through interaction with the tumor microenvironmentRyosuke Kashiwagi, Ryo Funayama, Shuichi Aoki, et al.
Surgical Case Reports|June 30, 2022
Pancreaticoduodenectomy for pancreatic head cancer with cavernous transformation of the portal vein: a case reportNaohiro Hirano, Masahiro Iseki, Takanori Morikawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 16, 2010
[Adverse events in patients treated with capecitabine as adjuvant chemotherapy after surgery for colorectal cancer--countermeasures against hand-foot syndrome]Takeshi Suto, Koushiro Ishiyama, Hiroshi Yabuki, et al.
International Cancer Conference Journal|April 3, 2026
A case of perihilar cholangiocarcinoma with peritoneal dissemination that achieved a pathological complete response using immune checkpoint inhibitors: A case reportTakehiko Saijo, Hideaki Sato, Shuichi Aoki, et al.
Pancreas|May 6, 2025
Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Preceding Neoadjuvant Therapy for Pancreatic Ductal AdenocarcinomaKoetsu Inoue, Masamichi Mizuma, Fuyuhiko Motoi, et al.
Cancer Science|October 8, 2024
Usefulness of multigene liquid biopsy of bile for identifying driver genes of biliary duct cancersShin Ito, Mika Ando, Shuichi Aoki, et al.
Trials|May 17, 2024
Superiority trial for the development of an ideal method for the closure of midline abdominal wall incisions to reduce the incidence of wound complications after elective gastroenterological surgery: study protocol for a randomized controlled trialShota Fukai, Yuki Mizusawa, Hiroshi Noda, et al.
Annals of Surgical Oncology|September 1, 2025
Favorable Response Defined by CA19-9 Reduction After Neoadjuvant Treatment for Pancreatic CancerYuya Ashitomi, Fuyuhiko Motoi, Atsushi Oba, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Reprogramming Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 TherapyJiang Chen, Zohreh Amoozgar, Xin Liu, et al.
Pageof 4